Biology

The regional coalition of health systems is reevaluating the role of race in tools used to assess kidney and lung function and other health conditions.

Voxelotor, which was sold under the brand name Oxbryta, was suddenly pulled from the market over safety concerns from clinical trials outside the U.S.

The decision to have children is a complicated one - finances, relationships, morality and more. When faced with the choice, people are opting to have fewer kids, if any.

The gene therapy comes seven years after another research group at the university helped come up with the first FDA approved gene therapy for an inherited disease.

For 40 years, a network of community gardens has kept Puerto Rican folk remedies alive.

Workers in Philly's Old City hit upon a historic cemetery with hundreds of people. It took years to study, identify and rebury them.

Pads and tampons will be available in all bathrooms in county buildings, including courthouses, health and human services buildings, parks and historic sites.

Blood donations were down 25% nationally in July compared to the same time last year, according to the American Red Cross.

This comes as the relatively new leadership grapples with how to approach their collection, which includes a lot of human remains.

We talk to NPR host Peter Sagal before a live taping of Wait Wait in Philly. And, a new study found monkeys in Puerto Rico became kinder after Hurricane Maria.

Diets have long been about calories, or an emphasis on different nutrients — but with precision nutrition, the approach is personalized.

When it comes to rare diseases like HLH, the Zangrilli family says insurance can end up being the barrier to desperately needed treatment.

State environmental officials say a rebound in bald eagle populations stems from volunteers and professionals who nurtured hatchlings, guarded nests and educated the public.

Biopharmaceutical company Incyte expects to relocate 400 employees from its Pennsylvania offices and expand in downtown Wilmington by 2026.

Philadelphia is home to nearly 10% of the world’s cell and gene therapy companies, employing about 7,000 people, according to the study.